240 related articles for article (PubMed ID: 19744613)
1. Pharmacogenetics in cardiovascular antithrombotic therapy.
Marín F; González-Conejero R; Capranzano P; Bass TA; Roldán V; Angiolillo DJ
J Am Coll Cardiol; 2009 Sep; 54(12):1041-57. PubMed ID: 19744613
[TBL] [Abstract][Full Text] [Related]
2. Pharmacogenetics in cardiovascular antithrombotic therapy.
Marín F; Roldán V; González-Conejero R; Corral J
Curr Med Chem Cardiovasc Hematol Agents; 2005 Oct; 3(4):357-64. PubMed ID: 16250866
[TBL] [Abstract][Full Text] [Related]
3. The pharmacogenetics of antiplatelet drugs.
Marín F; Roldán V; González-Conejero R; Corral J
Curr Opin Investig Drugs; 2007 Mar; 8(3):213-8. PubMed ID: 17408116
[TBL] [Abstract][Full Text] [Related]
4. Pharmacogenetics of antithrombotic drugs.
Tàssies D
Curr Pharm Des; 2006; 12(19):2425-35. PubMed ID: 16842189
[TBL] [Abstract][Full Text] [Related]
5. [New antithrombotic drugs in cardiovascular disease].
Golino P; Cimmino G; Porchetta I; Spadera M; Volpe M; Calabrò R
G Ital Cardiol (Rome); 2006 Feb; 7(2):109-18. PubMed ID: 16532722
[TBL] [Abstract][Full Text] [Related]
6. Pharmacogenomics of G protein-coupled receptor ligands in cardiovascular medicine.
Rosskopf D; Michel MC
Pharmacol Rev; 2008 Dec; 60(4):513-35. PubMed ID: 19074621
[TBL] [Abstract][Full Text] [Related]
7. Antithrombotic therapy in the elderly.
Capodanno D; Angiolillo DJ
J Am Coll Cardiol; 2010 Nov; 56(21):1683-92. PubMed ID: 21070918
[TBL] [Abstract][Full Text] [Related]
8. [Targets of antithrombotic drugs].
Drouet L; Ripoll L
Med Sci (Paris); 2006 Oct; 22(10):887-94. PubMed ID: 17026945
[TBL] [Abstract][Full Text] [Related]
9. Understanding the genetic causes of inter-patient variability. Clinical relevance with focus on cardiovascular drugs.
Ginghină C; Stănescu R; Coman IM; Bărbari L; Popescu BA
Rom J Intern Med; 2007; 45(4):313-9. PubMed ID: 18767405
[TBL] [Abstract][Full Text] [Related]
10. Polymorphism of human cytochrome P450 enzymes and its clinical impact.
Zhou SF; Liu JP; Chowbay B
Drug Metab Rev; 2009; 41(2):89-295. PubMed ID: 19514967
[TBL] [Abstract][Full Text] [Related]
11. The prescribing patterns of antithrombotic agents for prevention of recurrent ischemic stroke.
Po HL; Lin YJ; Hseuh IH
Acta Neurol Taiwan; 2009 Jun; 18(2):98-103. PubMed ID: 19673361
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular pharmacogenetics.
Myburgh R; Hochfeld WE; Dodgen TM; Ker J; Pepper MS
Pharmacol Ther; 2012 Mar; 133(3):280-90. PubMed ID: 22123178
[TBL] [Abstract][Full Text] [Related]
13. Pharmacogenomics and cardiovascular drugs: need for integrated biological system with phenotypes and proteomic markers.
Siest G; Marteau JB; Maumus S; Berrahmoune H; Jeannesson E; Samara A; Batt AM; Visvikis-Siest S
Eur J Pharmacol; 2005 Dec; 527(1-3):1-22. PubMed ID: 16316654
[TBL] [Abstract][Full Text] [Related]
14. Pharmacogenetics: improving drug and dose selection.
Bhathena A; Spear BB
Curr Opin Pharmacol; 2008 Oct; 8(5):639-46. PubMed ID: 18762278
[TBL] [Abstract][Full Text] [Related]
15. Pharmacogenetics in heart failure: promises and challenges.
de Boer RA; van der Harst P; van Veldhuisen DJ; van den Berg MP
Expert Opin Pharmacother; 2009 Aug; 10(11):1713-25. PubMed ID: 19558337
[TBL] [Abstract][Full Text] [Related]
16. Modification of coronary artery disease using antithrombotic therapy.
Drake-Holland AJ
J Cardiovasc Risk; 1995 Jun; 2(3):229-33. PubMed ID: 7584798
[TBL] [Abstract][Full Text] [Related]
17. [Pharmacogenetics in cardiovascular diseases therapy--treatment according guidelines or according the individual requirement?].
Bultas J
Cas Lek Cesk; 2010; 149(10):476-81. PubMed ID: 21121138
[TBL] [Abstract][Full Text] [Related]
18. Plasminogen activators: a comparison.
Baruah DB; Dash RN; Chaudhari MR; Kadam SS
Vascul Pharmacol; 2006 Jan; 44(1):1-9. PubMed ID: 16275118
[TBL] [Abstract][Full Text] [Related]
19. Pharmacogenetics in Oral Antithrombotic Therapy.
Maier CL; Duncan A; Hill CE
Clin Lab Med; 2016 Sep; 36(3):461-72. PubMed ID: 27514462
[TBL] [Abstract][Full Text] [Related]
20. [Pharmacogenetics--new perspectives in the treatment of cardiovascular diseases].
Dzida G
Kardiol Pol; 2004 Mar; 60(3):304-8. PubMed ID: 15156230
[No Abstract] [Full Text] [Related]
[Next] [New Search]
